(VIANEWS) – MicroVision stock price declined 26.18% over 10 sessions from EUR2.33 to EUR1.72 after experiencing an upward trend during one session, even as NASDAQ index experienced a decrease of 0.27% to EUR16,384.47 due to an upward trend during another. MicroVision’s last closing price is EUR1.72, which is 79% off of its 52-week high of EUR8.20.
About MicroVision
MicroVision, Inc. is a technology company that specializes in the development and sale of lidar sensors and software for automotive safety and autonomous driving applications. Their range of lidar sensors includes perception software as well as validation tools designed for OEMs, advanced driver assistance systems (ADAS) providers and autonomous vehicle applications. Furthermore, MicroVision’s lidar products include MAVIN DR dynamic view lidar systems as well as MOSAIK software which automates data classification. Founded in 1993 and located in Redmond Washington.
Yearly Analysis
On the basis of available information, here is an investment outlook for MicroVision stock:
Yearly High and Bottom Values of 2016/2017.
MicroVision’s stock is currently trading at EUR1.72, below its 52-week low of EUR1.82. This indicates that performance has been subpar over the last year; however, past performance should not be taken as an indication of future results.
MicroVision anticipates sales growth for this year of 1026.5%, which represents an impressive jump over last year’s growth rates. However, such exponential expansion may not be sustainable long term; next year MicroVision projects to experience 902.7% sales growth – still an impressive rate but lower than this year.
Earnings Before Interest, Taxes, Depreciation and Amortization
MicroVision currently stands with an EBITDA value of -15.3, indicating it does not generate positive cash flow from its operations. A negative EBITDA should serve as a warning signal to investors as this shows they do not have sufficient capital available to fund operations and might therefore not be profitable or meet operational costs.
MicroVision stock has performed poorly overall, and its negative EBITDA is cause for alarm. Although sales growth expectations may appear impressive at first glance, investors must remember that such rates may not be sustainable in the long run and perform further analysis before making investment decisions.
Technical Analysis
MicroVision’s stock price is trading below both its 50-day and 200-day moving averages, which indicates a downward trend in its price. Furthermore, volume has fallen below its average figure, signaling decreased investor interest. Volatility has been relatively low – highest weekly, monthly, and quarterly average volatility was 4.07% respectively (highest weekly amplitude: 5.49 percent and 5.49 percent and 3.69 respectively).
MicroVision’s stock is currently overbought, which could signal a correction. Investors should monitor its movements closely and consider taking profits or making necessary adjustments as the situation warrants. Furthermore, this might provide an ideal buying opportunity at lower price points in the market.
Quarter Analysis
MicroVision recently reported a remarkable 4800% sales growth rate for their next quarter, which could indicate high demand and rising popularity for their products and services. This astounding sales boost could be attributable to various factors like new product releases, market expansion or increased marketing efforts.
Growth Estimates Quarters
MicroVision recently issued estimates for their current quarter, which they forecasted would decline 12.5% from last quarter’s. But, the company remains optimistic, projecting positive growth rate of 18.2% for next quarter. These projections may fluctuate depending on various factors and market conditions affecting business operations, so investors must closely monitor MicroVision’s financial performance and updates for best results.
Equity Analysis
MicroVision currently boasts an EPS of EUR-0.45 for the trailing twelve months, signifying that no profits are currently being generated for its shareholders.
Return on Equity (ROE) for the twelve trailing months was negative at 89.3%, suggesting that shareholders’ equity is not being used effectively to generate profits for them.
These financial indicators suggest that MicroVision is currently facing difficulties with regards to profitability and shareholder value, so investors should carefully consider this before making investment decisions.
More news about MicroVision (MVIS).
